Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

9.240 +0.070 (+0.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday? ↗
Integra LifeSciences surpasses expectations with first-quarter revenues of $368.9 million, reporting growth in Codman Specialty Surgical and updates fiscal year 2024 guidance. 
Via Benzinga
News headline image
IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024 ↗
IART stock results show that Integra Lifesciences met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
From Pomerantz LLP
Via GlobeNewswire
News headline image
NASDAQ:IART is probably undervalued for the fundamentals it is displaying. ↗
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
News headline image
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Analyst Scoreboard: 5 Ratings For Integra Lifesciences ↗
 
Via Benzinga
News headline image
Recap: Integra Lifesciences Q4 Earnings ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 7 Takes On Integra Lifesciences ↗
 
Via Benzinga
News headline image
NASDAQ:IART, an undervalued stock with good fundamentals. ↗
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
News headline image
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal ↗
Integra LifeSciences Holdings Corporation (NASDAQ: IART) agreed to acquire Acclarent Inc. 
Via Benzinga
News headline image
The Latest Analyst Ratings for Integra Lifesciences ↗
 
Via Benzinga
News headline image
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
4 Analysts Have This to Say About Integra Lifesciences ↗
 
Via Benzinga
News headline image
INTEGRA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
INTEGRA LIFESCIENCES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
INTEGRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
ROSEN, A LEADING NATIONAL FIRM, Encourages Integra LifeSciences Holdings Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important November 13 Deadline in Securities Class Action - IART
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
IART DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ: IART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Integra LifeSciences Holdings Corporation
From Bernstein Liebhard LLP
Via GlobeNewswire
Investor Notice: Deadline on November 13, 2023 Coming Up in Lawsuit Against Integra LifeSciences Holdings Corporation (NASDAQ:IART) ↗
San Diego, CA -- (SBWIRE) -- 11/06/2023 -- The Shareholders Foundation announced that a deadline is coming up on November 13, 2023 in the lawsuit filed for certain investors of Integra LifeSciences... 
Via SBWire
Topics Lawsuit
News headline image
ROSEN, LEADING INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INTEGRA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, A LEADING LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IART
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART
WHY: NEW YORK, NY - (NewMediaWire) - November 01, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integra LifeSciences Holdings Corporation (NASDAQ:... 
Via NewMediaWire
Topics Lawsuit
News headline image
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Integra LifeSciences Holding Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.